Categories Cancer

Visible Residual Disease Following Interval Debulking in Ovarian Cancer Is Associated With …

Visible Residual Disease Following Interval Debulking in Ovarian Cancer Is Associated With … Maintenance therapy with niraparib (Zejula) was associated with a significant reduction in the risk of disease progression in patients who had interval debulking surgery (IDS) and visible residual disease (VRD), according to results of a post hoc analysis of the phase 3 […]

Read More
Categories Cancer

CSF organises cancer awareness programme

CSF organises cancer awareness programme     20-Mar-2021 | By Our Staff ReporterIMPHAL, Mar 20: Chhabi Sahayog Foundation(CSF), Delhi conducted Cancer warriors felicitation and Cancer Awareness Programme today at AIIMS Hospital, New Delhi. The programme was dedicated to the late beloved cancer warrior Swagata Show who lost his battle against cancer recently. The event was attended by […]

Read More
Categories Multiple Myeloma

FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And …

FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And … Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Therapeutics, Inc. (NASDAQ: RUBY) was among the biggest gainers of the week after the biopharma reported […]

Read More
Categories Multiple Myeloma

Bromodomain Testis Specific Protein Market Size, Company Profiles And Key Figures Reviewed In …

Bromodomain Testis Specific Protein Market Size, Company Profiles And Key Figures Reviewed In … The report titled Global Bromodomain Testis Specific Protein Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Bromodomain Testis Specific […]

Read More